Moderna seeks approval to give its Covid vaccine to children in Europe

0

Covid vaccine manufacturer Moderna today asked European drug regulators for permission to give its shot to children.

The US-based company has submitted its request to the European Medicines Agency, aiming to distribute its vaccine to 12-17 year olds.

Data showed that two doses of the jab was up to 100 percent effective in blocking Covid symptoms in adolescents, while one shot was 93 percent effective. No additional side effects were recorded.

MailOnline has approached Moderna to find out when it plans to submit final safety and efficacy data to UK regulators.

Moderna found that the two-dose vaccine was 100 percent effective in a study that tested 2,500 children (Pictured: A teen gets the shot in Florida, US)

Moderna found that the two-dose vaccine was 100 percent effective in a study that tested 2,500 children (Pictured: A teen gets the shot in Florida, US)

The Medicines and Healthcare products Regulatory Agency (MHRA), which oversees the safety of medicines in the UK, has to give the green light for use in Britain.

But No10 has yet to decide whether children will even get jabs, despite sources saying Whitehall is preparing to vaccinate schoolchildren in August.

MHRA bosses last week approved the Pfizer-BioNTech vaccine — which is an mRNA shot like Moderna’s — for people over the age of 12. It had already given the green light for people over 15 in December.

Moderna plans to ask the US Food and Drug Administration, which plays the same role in the US, and other agencies around the world to expand the use of its vaccine to younger age groups.

It presented data from a trial involving nearly 2,500 children who received the two-dose vaccine.

The results showed there were no cases of coronavirus and no safety concerns among fully vaccinated volunteers.

Figures from British daily Covid, released on June 6, show that 5,341 people tested positive for the virus, four died from the virus and 154 were hospitalized, while the total posted doses of vaccines reached 27.7 million.

Figures from British daily Covid, released on June 6, show that 5,341 people tested positive for the virus, four died from the virus and 154 were hospitalized, while the total posted doses of vaccines reached 27.7 million.

WALES JOINS MONDAY FOR JABS FOR ALL Over 18s ALLE

Wales today committed to offering jabs to all over 18s by Monday.

Prime Minister Mark Drakeford said the milestone will be reached six weeks ahead of the UK’s target of giving vaccines to everyone over 18 by the end of July.

Wales has given a first shot to 2.18 million people, or 86 percent of the adult population, which is currently the best record of any country in the world.

However, Wales lags behind England and Scotland in the proportion of the population that have received both doses.

Drakeford told a news conference in Cardiff: ‘We will be offering vaccination to all eligible adults six weeks ahead of schedule and we expect to achieve 75 per cent vaccination in all priority and age groups one month ahead of the target.

“This is a remarkable achievement and a tribute to the hard work of everyone involved in the program – to everyone who does the complex work of planning behind the scenes and to the thousands of people who vaccinate and help run the clinics in the whole country. ‘

He said the government would now “change our efforts to accelerate second doses,” aiming to reach the entire population by September.

“Depending on the delivery, we are confident that we can deliver second doses as quickly and as successfully as the first doses,” he said.

The updated strategy expects to deliver approximately 28,000 second doses per day during the summer months.

Moderna calculated that the Covid vaccine was therefore up to 100 percent effective in blocking symptoms after two doses.

Mild or moderate side effects included sore arms after the injection, as well as headache, fatigue, muscle aches and chills after the second injection.

Stéphane Bancel, Moderna’s chief executive officer, said the company’s vaccine was “highly effective” at preventing adolescents from contracting the coronavirus.

An independent committee will continue to review the safety data from the trial and all participants will be monitored for 12 months from their second injection.

The company has already asked Canadian regulator Health Canada for approval to use the shot in 12 to 18-year-olds and plans to ask the U.S. Food and Drug Administration and other agencies around the world to stop use of its vaccine. extend to younger age groups.

The UK’s Joint Vaccination and Immunization Committee (JCVI) – which normally decides who should receive a vaccine – has yet to state its position on giving the vaccine to children.

Health Secretary Matt Hancock told the House of Commons today that despite evidence showing that the impact of Covid on children is “usually minimal”, there is a “higher transmissibility among children”.

He also confirmed that he has asked the JCVI to advise the government on vaccinating 12 to 17 year olds. “We will listen to that clinical advice, just as we have done during the pandemic,” Mr Hancock said.

While the decision is yet to be made, the now-dominant Delta variant continues to spread in the UK.

Public Health England said the strain, which was first discovered in India, has overtaken the Alpha variety to become the dominant variety in the UK.

The data from PHE suggest that the Delta variant poses a greater risk of hospitalization and is spreading more quickly across schools in England.

Data also shows that one shot is less effective against the variant, while two offer better protection.

Some scientists say it is necessary to prick children to stop the spread of Covid and protect high-risk children.

But experts have raised concerns about giving vaccines to children in wealthier countries, rather than high-risk individuals in poorer countries.

Professor Andrew Pollard, director of the Oxford Vaccine Group, said it is “completely wrong” to roll out vaccines to children who have a “near zero” risk of serious illness or death from Covid, ahead of priority groups from poorer countries. Nations.

The scientists, who helped develop the Oxford/AstraZeneca Covid-19 shot, said: the All Party Parliamentary Group on Coronavirus last month that it felt ‘completely wrong’ for that to happen.

More than six million young people under the age of 17 have received the Pfizer-BioNTech vaccine in the US after becoming the first country to approve the vaccine for children last month.

.